Related Experiment Video
Updated: Jun 26, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Dominant-negative loss of PPARgamma function enhances smooth muscle cell proliferation, migration, and vascular
Dane Meredith1, Manikandan Panchatcharam, Sumitra Miriyala
1Carolina Cardiovascular Biology Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Objective:
The peroxisome proliferator activated receptor-gamma (PPARgamma) protein is a nuclear transcriptional activator with importance in diabetes management as the molecular target for the thiazolidinedione (TZD) family of drugs. Substantial evidence indicates that the TZD family of PPARgamma agonists may retard the development of atherosclerosis. However, recent clinical data have suggested that at least one TZD may increase the risk of myocardial infarction and death from cardiovascular disease. In this study, we used a genetic approach to disrupt PPARgamma signaling to probe the protein's role in smooth muscle cell (SMC) responses that are important for atherosclerosis.
Methods And Results:
SMC isolated from transgenic mice harboring the dominate-negative P465L mutation in PPARgamma (PPARgamma(L/+)) exhibited greater proliferation and migration then did wild-type cells. Upregulation of ETS-1, but not ERK activation, correlated with enhanced proliferative and migratory responses PPARgamma(L/+) SMCs. After arterial injury, PPARgamma(L/+) mice had a approximately 4.3-fold increase in the development of intimal hyperplasia.
Conclusions:
These findings are consistent with a normal role for PPARgamma in inhibiting SMC migration and proliferation in the context of restenosis or atherosclerosis.
Insights
Peroxisome proliferator activated receptor-gamma (PPARgamma) normally inhibits smooth muscle cell migration and proliferation. Disrupting PPARgamma signaling in mice accelerated atherosclerosis development and intimal hyperplasia after arterial injury.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Diabetes Research
Background:
- Peroxisome proliferator activated receptor-gamma (PPARgamma) is a nuclear receptor targeted by thiazolidinediones (TZDs) for diabetes treatment.
- PPARgamma agonists are thought to slow atherosclerosis, but some TZDs may increase cardiovascular risk.
- The role of PPARgamma in smooth muscle cell (SMC) function related to atherosclerosis requires further investigation.
Purpose of the Study:
- To investigate the role of PPARgamma signaling in SMC proliferation and migration.
- To determine the in vivo consequences of disrupted PPARgamma signaling on atherosclerosis development.
Main Methods:
- Genetic disruption of PPARgamma signaling using a dominant-negative mutation (P465L) in mice.
- In vitro analysis of SMC proliferation and migration from PPARgamma(L/+) mice.
- Assessment of intimal hyperplasia in PPARgamma(L/+) mice after arterial injury.
Main Results:
- PPARgamma(L/+) SMCs showed increased proliferation and migration compared to wild-type cells.
- Upregulation of ETS-1 correlated with enhanced SMC proliferation and migration.
- PPARgamma(L/+) mice exhibited a 4.3-fold increase in intimal hyperplasia following arterial injury.
Conclusions:
- PPARgamma plays a normal inhibitory role in SMC migration and proliferation.
- These findings suggest PPARgamma signaling is protective against atherosclerosis and restenosis.
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway
Negative Regulator Molecules
Regulation of Angiogenesis and Blood Supply
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
